Vimta Labs Limited (NSE:VIMTALABS)
India · Delayed Price · Currency is INR 392.90
-15.30 (-3.75%)
Apr 2, 2026, 10:30 AM IST
Vimta Labs Market Cap
Vimta Labs has a market cap or net worth of 18.17 billion as of April 1, 2026. Its market cap has decreased by -14.56% in one year.
Market Cap
18.17B
Enterprise Value
17.69B
Revenue
3.94B
Ranking
n/a
PE Ratio
24.51
Stock Price
392.90
Market Cap Chart
Since January 10, 2002, Vimta Labs's market cap has increased from 19.85M to 18.17B, an increase of 91,455.89%. That is a compound annual growth rate of 32.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 17.01B | -37.13% |
| Dec 31, 2025 | 27.06B | 22.39% |
| Dec 31, 2024 | 22.11B | 147.00% |
| Dec 29, 2023 | 8.95B | -7.56% |
| Dec 30, 2022 | 9.68B | 7.16% |
| Dec 31, 2021 | 9.04B | 134.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.59T |
| Apollo Hospitals Enterprise | 1.09T |
| Cipla | 1.00T |
| Medi Assist Healthcare Services | 22.64B |
| Dishman Carbogen Amcis | 22.37B |
| Solara Active Pharma Sciences | 21.33B |
| Panacea Biotec | 19.59B |